Introduction
The term small for gestational age (SGA) is used to describe a neonate who is smaller than average after adjusting for sex and gestational age (GA). SGA infants usually have a birth weight below the 10th percentile for GA [1]. Some infants born SGA, particularly due to intrauterine growth restriction (IUGR), suffer acute and chronic consequences. In the neonatal period, some suffer from perinatal events, such as hypoglycemia, gastro-esophageal reflux, and hypothermia [2]. Such individuals can be and remain short in stature or suffer premature adrenarche and polycystic ovarian syndrome [3,4]. Furthermore, SGA individuals demonstrate significantly increased risks for obesity, hypertension, dyslipidemia, insulin resistance, type 2 diabetes mellitus, and cardiovascular diseases (CVD) from childhood to adulthood [2]. For proper assessment and management of SGA individuals, up-to-date, ethnicity-specific birth length or birth weight references according to GA are needed [5]. Many countries, including the United States, have reported new birth weight or birth length references by sex and GA, as the old references no longer fit the contemporary population [6-11]. The new references and cutoffs can be used to identify children at risk for short adult stature and future metabolic disease. Previously, we reported Korean birth weight references according to GA and sex [12]. However, birth length references based on the Korean population remained absent at the time of this study. Thus, the objectives of this study were as follows: (1) to create sex-specific birth length reference data for Koreans; (2) to create a sex-specific birth length cutoff to define SGA; and (3) to compare Korean-specific birth length reference data and cutoffs to those of other countries.
Materials and methods
1. Study subjects
This study was performed using data from the 4th Korean National Health and Nutrition Examination Survey (KNHANES-IV; 2007–2009), a cross-sectional and nationally representative survey with a multistage and stratified sampling design conducted by the Division of Chronic Disease Surveillance of the Korea Centers for Disease Control and Prevention. Written informed consent was secured from the respective caretakers of all participants before the study began, and the KNHANES-IV was conducted following ethical approval by the Institutional Review Board of Korea Centers for Disease Control and Prevention (No: 2007-02-04-P, 2008-04EXP-01-C, 2009-01CON-03-2C). In the KNHANESIV, the birth weight and birth length of children 1–3 years of age (n=895, representing 42,756 subjects) were available. Those without birth length were excluded (n=52). Thus, the final analytical sample consisted of 843 subjects (male, 459; female, 384).
2. Reference birth weights and lengths for 36-37 week and 38- to 41-week gestational ages
In the KNHANES-IV, GA was identified using the closedended question "Was your baby born between the expected birth date±2 weeks?" If the answer was yes, the baby was defined as full-term (38–41 weeks). When the birth date was between 2–4 weeks earlier than expected, the baby was designated as GA 36–37 weeks. For reference, a GA of 38 weeks represented 38 weeks + 0–6 days. Multiple births (n=10) were excluded, as the negative impact on intrauterine growth is well known. Thus, we used data of singleton newborns. We further excluded "extreme outliers," which were defined as value > 2 times the interquartile range (25th to 75th percentiles) above the third quartile for each GA [13]. There were 6 extreme outliers based on the birth length and 3 based on birth weight. Those with a GA below 36 (n=6) or an unspecified GA (n=18) were also excluded. Thus, data of 67 (39 males) singleton newborns with GA of 36–37 weeks and data of 736 (399 males) with GA of 38–41 weeks were used for reference. The 3rd, 10th, 25th, 50th, 75th, 90th, and 97th percentiles for male and female birth lengths were calculated.
4. Statistical analysis
All statistical analyses were performed using SPSS ver. 17.0 (SPSS Inc., Chicago, IL, USA). The P-values of <0.05 were considered significant. The data are presented as the mean±standard deviation concerning the percentile values for birth weight and length according to GA of 36–37 weeks and of 38–41 weeks.
Results
1. Subject characteristics
The characteristics of the study subjects are presented in Table 1. The 843 subjects in this study were born between 2005 and 2009 in Korea. The mean birth length was 50.7±2.9 cm, and the mean birth weight was 3,283±438 g. Female infants had lower birth lengths and birth weights than male infants (50.2±3.2 cm vs. 51.1±2.7 cm, 3,225±464 g vs. 3,327±413 g, respectively; P<0.001). There was no difference in birth weight concerning vaginal delivery and caesarean section. However, the birth lengths of infants born by caesarean section were shorter those born by vaginal delivery (50.4±3.4 cm vs. 50.9±2.6 cm, respectively; P=0.046). Full-term neonates comprised 91.3% of the participants (n=770), and preterm neonates younger than 37 weeks made up 8.7% (n=73).
2. Percentile distributions of birth length and birth weight by sex
The mean and percentiles of birth length and weight according to GA of males are presented in Table 2, and the corresponding female data are presented in Table 3. In creating the percentiles, outliers and twins were excluded; therefore, data from 736 (399 males) singleton infants born between 38–41 weeks and from 67 infants born between 36–37 weeks were used. At full-term, the 10th percentile birth length was 48 cm in both males and females, the 10th percentile birth weight was 2,900 g for males and 2,828 g for females, and the 3rd percentile birth length was 47 cm for males and 46 cm for females.
3. Prevalence of SGA
The prevalence (%) of SGA in full-term neonates when using the 10th percentile as the cutoff point for either birth length or weight is shown in Fig. 1. In full-term neonates, a total of 745 subjects (including outliers) were divided based on birth length and weight. Of the subjects, 86.3% (n=643) possessed a greater than 10th percentile value for both birth length and weight (group I). The others fell into 3 groups: 3.9% (n=29) were of normal length and low weight (group II); 7.0% (n=52) were short and of normal weight (group III); and 2.8% (n=21) were short and of low weight (group IV). Considering SGA based only on birth weight, short newborn infants of normal weight (group III) were neglected from all SGA classifications, consisting of 51% of all individuals.
Discussion
In this study, we introduced references for Korean birth length and weight based on the nation-wide survey data from the KNHANES-IV. This new Korean birth length data may be useful in assessing long-term health risks, such as short stature in childhood and metabolic risk in adulthood for children born with SGA. Furthermore, we showed that approximately half of infants classified as SGA, who are short but have a normal birth weight, might be misclassified as appropriate gestational age (AGA); this supports the need for updates and Korean-specific reference curves for birth length.
Contemporary ethnicity-specific birth weight references are needed to identify SGA neonates who might suffer from acute and chronic consequences [5]. Some SGA neonates are born following IUGR, and the suboptimal fetal growth occurring in IUGR fetuses is an important cause of perinatal mortality and morbidity [2]. Furthermore, SGA children have demonstrated significantly increased risks for obesity, hypertension, dyslipidemia, insulin resistance, type 2 diabetes mellitus, and cerebrovascular disease from childhood to adulthood [2,14]. Furthermore, approximately 13% of children born with SGA remain short-statured and constitute a significant proportion of adults with short stature [15]. In a Swedish birth cohort, SGA infants demonstrated a 7-fold higher risk of short stature in adulthood compared to non-SGA infants [4]. They also revealed that the majority (61.7%) of the short newborn population may be misclassified as AGA if classified only in terms of birth weight. Furthermore, a slightly higher relative risk of short stature was obtained using birth length rather than birth weight to define SGA [16,17]. Additionally, the postnatal growth patterns were similar in SGAL and SGAW. In our study, when SGA was defined only by birth weight, 71.2% of short newborns were classified as AGA.
Growth hormone (GH) treatment for SGA children is standard practice. Many studies have shown that adult height is increased by GH therapy in these children [18,19]. Short-term GH treatment reduces body fat while promoting lean body mass and may reduce cardio-metabolic risk in SGA children [20]. Furthermore, a study from Sweden reported that GH therapy showed a significant and cost-effective improvement in health and quality of life [21]. Thus, the U.S. Food and Drug Administration and the European Medicines Agency have approved GH treatment for children with short stature who are born SGA. In Korea, medical insurance benefits have been applied to GH treatment for SGA children since 2014. Therefore, it is important to define SGA not only to reduce perinatal morbidity, but also to manage short stature in children and adolescents.
Moreover, it is well known that there are racial and ethnic differences in birth weight and birth length [22-24]. Furthermore, significant interactions have been found between race and maternal variables, especially after beginning antenatal care. Thus, ethnicity- and sex-specific references for birth weight and birth length are important. As the KNHANES-IV data did not show the specific GA, we first compared the birth weight reference of this study with that in our previous work concerning Korean birth weight. The values for the 10th, 50th, and 90th percentiles of this study for full-term (GA of 38–41 weeks) were between a GA of 39 weeks and a GA of 40 weeks in previous studies concerning both sexes [25].
Compared to the new USA intrauterine growth data of a GA of 39 weeks and a GA of 40 weeks [6], our references for full-term birth length values were similar to the USA data for a GA of 40 weeks. The 3rd, 10th, 25th, 50th, 75th, 90th, and 97th percentiles for birth length at a GA of 40 weeks were 46.9, 48.4, 49.9, 51.6, 53.2, 54.7, and 56.1 cm, respectively, in male neonates and 46.1, 47.6, 49.1, 50.8, 52.4, 53.8, and 55.1 cm in female neonates. Compared to the new Japanese neonatal anthropometric charts for GA [11], our reference values for the full term were higher than the former. The 3rd, 10th, 50th, 90th, and 97th percentiles for the birth length of a GA of 40 weeks were 45.9, 47.1, 49.4, 51.7, and 52.7 cm, respectively, in both sexes. These variations can mainly be attributed to ethnic differences, which were previously discussed in a study of the Korean reference for birth weight [12]. The other reason for these differences is that the new Japanese charts were based on data from subjects born only via vaginal delivery. Compared to other countries' GA of 40 weeks, the Korean birth length was similar to that of Turkey and Israel and higher than that of Indonesia [26-28].
There were some limitations in the present study. First, the most important limitation of the provided reference is that, like other population-based studies, it is cross-sectional in nature rather than comprised of longitudinal measurements [5,29]. Second, there was a small number of subjects in the KNHANESIV, and the specific GA per subject was lacking, which invalidated the study's ability to create a reference concerning length for GA. Third, it was not easy to distinguish the infant of a multicultural family, but their portion is not higher than the present, so the effect on the result was considered insignificant. Thus, further research, including greater numbers of subjects with specified GAs, is needed concerning Koreans.
In conclusion, we calculated the means and percentiles for birth length in Korean neonates based on data from the KNHANES-IV. We created new reference curves using the 10th percentile as the cutoff point for birth length and weight in Korean neonates. We also created a new cutoff for SGA by birth length. As some SGA neonates experienced short-term and long-term health risks, these data and curves provide useful information for not only Korean endocrinologists, but also for other specialists, including neonatologists, for planning research or targeting prevention of metabolic diseases, such as obesity, diabetes, and CVD.
PDF Links
PubReader
ePub Link
XML Download
Full text via DOI
Full text via PMC
Download Citation
Print
